CD44, TGM2 and EpCAM as novel plasma markers in endometrial cancer diagnosis

BACKGROUND: Endometrial cancer (EC) is the most common malignancy of the female reproductive tract. Despite years of research, the accurate screening strategy is still not available in this disease and it is usually diagnosed only after the clinical signs are present. The recent technological advanc...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMC Cancer
Asıl Yazarlar: Torres, Anna, Pac-Sosińska, Małgorzata, Wiktor, Krzysztof, Paszkowski, Tomasz, Maciejewski, Ryszard, Torres, Kamil
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2019
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6489287/
https://ncbi.nlm.nih.gov/pubmed/31035965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-5556-x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller